Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Donato

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Lymphokine and Cytokine Research|February 1, 1994
Positive and negative selection for tumor necrosis factor responsiveness reveals an inhibitory role for EGF receptor in TNF-induced antiproliferationK Nishikawa, J Rotbein, D Vijjeswarapu, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1996
Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cellsM G Rosenblum, L Cheung, S K Kim, et al.
Biochemical Pharmacology|June 14, 1996
Regulation of epidermal growth factor receptor activity by crotoxin, a snake venom phospholipase A2 toxin. A novel growth inhibitory mechanismN J Donato, C A Martin, M Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivityN J Donato, M Perez, H Kang, et al.
Journal of Cellular Biochemistry|January 28, 2006
Hyperthermia engages the intrinsic apoptotic pathway by enhancing upstream caspase activation to overcome apoptotic resistance in MCF-7 breast adenocarcinoma cellsJ Klostergaard, M E Leroux, E Auzenne, et al.
Cancer Research|September 1, 1992
Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptorK Nishikawa, M G Rosenblum, R A Newman, et al.
Leukemia|September 10, 2005
Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemiaH Gao, B-N Lee, M Talpaz, et al.
Leukemia|February 26, 2011
p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cellsL F Peterson, E Mitrikeska, D Giannola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852R Perez-Soler, N J Donato, D M Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancerD M Shin, N J Donato, R Perez-Soler, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Lymphokine and Cytokine Research|February 1, 1994
Positive and negative selection for tumor necrosis factor responsiveness reveals an inhibitory role for EGF receptor in TNF-induced antiproliferationK Nishikawa, J Rotbein, D Vijjeswarapu, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1996
Cellular resistance to the antimelanoma immunotoxin ZME-gelonin and strategies to target resistant cellsM G Rosenblum, L Cheung, S K Kim, et al.
Biochemical Pharmacology|June 14, 1996
Regulation of epidermal growth factor receptor activity by crotoxin, a snake venom phospholipase A2 toxin. A novel growth inhibitory mechanismN J Donato, C A Martin, M Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivityN J Donato, M Perez, H Kang, et al.
Journal of Cellular Biochemistry|January 28, 2006
Hyperthermia engages the intrinsic apoptotic pathway by enhancing upstream caspase activation to overcome apoptotic resistance in MCF-7 breast adenocarcinoma cellsJ Klostergaard, M E Leroux, E Auzenne, et al.
Cancer Research|September 1, 1992
Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptorK Nishikawa, M G Rosenblum, R A Newman, et al.
Leukemia|September 10, 2005
Imatinib mesylate suppresses cytokine synthesis by activated CD4 T cells of patients with chronic myelogenous leukemiaH Gao, B-N Lee, M Talpaz, et al.
Leukemia|February 26, 2011
p53 stabilization induces apoptosis in chronic myeloid leukemia blast crisis cellsL F Peterson, E Mitrikeska, D Giannola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1994
Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852R Perez-Soler, N J Donato, D M Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2001
Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancerD M Shin, N J Donato, R Perez-Soler, et al.
Pageof 3